Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and ...
The northward move in Marksans Pharma came after the company's wholly-owned subsidiary, Relonchem, received Marketing ...
In the complex pharmaceutical market, achieving high levels of brand memorability directly influences patient choices and adherence, making it a critical focus for marketing strategies.
Marksans Pharma advanced 2.61% to Rs 208.15 after the company's wholly owned subsidiary in the UK, Relonchem, has received marketing authorization for Baclofen Tablets from the UK Medicines and ...
Heather Gervais, CEO of Osso VR, discusses how technological advancements in VR are solving problems for pharmaceutical sales ...
Brand.com’s are connecting HCPs to information, with fewer hoops to jump through, courtesy of new digital tools promising to ...
Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to tighten its belt in anticipation of a generic heart med incursion later thi | ...
Novo Nordisk accepted back into UK pharma group after ‘sustained improvements’ get suspension lifted
Novo Nordisk has been accepted back into the fold. Two years after suspending Novo, the Association of the British ...
The rise of artificial intelligence (AI), digitalisation, wider adoption of tools for marketing automation, and numerous other technologies have significantly reshaped the world of pharma for the ...
Bluesky’s less formal and more community-driven environment also offers an opportunity for experimentation. Unlike X, where content must compete against a flood of real-time updates, Bluesky provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results